Shareholders Equity: The sum of preferred and common equity items.
NanoViricides, Inc. (NNVC) had Shareholders Equity of $11.07M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.22M |
|
-- |
|
-- |
|
$2.23M |
|
$-2.23M |
|
$0.01M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.23M |
|
$-2.10M |
|
19.85M |
|
19.85M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$5.30M |
|
$6.66M |
|
$6.97M |
|
$12.27M |
|
$1.20M |
|
-- |
|
-- |
|
$1.20M |
|
$11.07M |
|
$10.76M |
|
|
Shareholders Equity |
$11.07M |
21.59M |
|
| Cash Flow Statement Financials | |
$-3.64M |
|
$-0.08M |
|
$7.32M |
|
$1.56M |
|
$5.15M |
|
$3.59M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.06% |
|
-20.64% |
|
-18.10% |
|
-20.06% |
|
$0.51 |
|
$-0.19 |
|
$-0.18 |
|